MIR - Mirion Technologies to buy Computerized Imaging Reference Systems for $54 million

Computerized Imaging Reference Systems ('CIRS') provides medical imaging and radiation therapy phantoms serving the medical industry. CIRS specializes in designing, developing, and commercializing tissue equivalent medical imaging and radiation therapy phantoms for the radiotherapy and radio-diagnostic markets. CIRS will be integrated into Mirion’s (NYSE:MIR) Medical segment, expects to generate adjusted revenue and adjusted EBITDA of ~$16M and $5M, respectively, for the calendar year 2022. The purchase is anticipated to be accretive to Mirion’s adjusted EBITDA margins, excluding one-time costs related to the integration. In addition, Mirion (MIR) expects CIRS margins to improve via synergies over time as it leverages its global platform to catalyze efficiency gains. The transaction is expected to close in the fourth quarter of the calendar year 2021.

For further details see:

Mirion Technologies to buy Computerized Imaging Reference Systems for $54 million